[The Hill] Wyden, Grassley question hep C drug's high cost

[The Hill] Wyden, Grassley question hep C drug’s high cost

Two high-ranking senators have lent their voices to the chorus demanding to know why Gilead’s new hepatitis C drug Sovaldi costs $1,000 a pill.

Sens. Ron Wyden (D-Ore.), chairman of the Senate Finance Committee, and Chuck Grassley (R-Iowa), the Judiciary Committee’s ranking member, are asking the specialty drugmaker how they justify the high price of the medication, which can cost over $84,000 per treatment.

First Name*
Last Name*
Email*
CAPTCHA
FP1 Tracking: Basic Data
Origin URL Page Title Source URL Query String Date Time
FP1 Tracking: UTM Data
UTM Source UTM Medium UTM Campaign
FP1 Iterable: Lists
Lists
FP1 Iterable: Workflows
Workflows
Phone
This field is for validation purposes and should be left unchanged.

News & Updates

[The Hill] Wyden, Grassley question hep C drug’s high cost

Sign-up for updates